Results 161 to 170 of about 9,802 (262)

Diagnosis of B-cell lymphoproliferative disorder through concomitant management of medication-related osteonecrosis of the jaw: A case report [PDF]

, 2019
Buckley, James G., Champion, Allen F., Diecidue, Robert, Zhou, Ruifeng   +3 more
core   +1 more source

Effect of hyaluronic acid on the prevention of medication-related osteonecrosis of the jaw in a bisphosphonate-treated rat model. [PDF]

BMC Oral Health
Gachayev K, Şimşek Kaya G, Kaya M, Özalp Ö, Altunay B, Toru HS.   +5 more
europepmc   +1 more source

Bisphosphonate-associated jaw osteonecrosis

, 2005
Joseph A. Woelfel
openalex   +1 more source

A case of rheumatoid arthritis associated with bisphosphonate-related osteonecrosis of the jaw and methotrexate-associated lymphoproliferative disorde

, 2012
Yuko Minami, Yumiko Ohbayashi, Fumi Sawai, Keinoshin Wada, Minoru Miyake, Yoshiro Matsui   +5 more
openalex   +2 more sources

Clinical Pharmacist's Role in Preventing and Managing Drug-Induced Oral Ulceration: A Bisphosphonate Case in an Older Adult Care Setting. [PDF]

Case Rep Dent
Sano M, Iijima Y, Yamada M, Hino S, Shinogi M, Horie N, Kaneko T.   +6 more
europepmc   +1 more source

Histological findings on jaw osteonecrosis associated with bisphosphonates (BONJ) or with radiotherapy (ORN) in humans

, 2013
Daniela Carmagnola, Elena Canciani, Davide Sozzi, Federico Biglioli, Laura Moneghini, Claudia Dellavia   +5 more
openalex   +1 more source

Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) Knowledge in Senior Dental and Medical Students. [PDF]

Cureus
Develi T, Akgok MG, Wardak M.
europepmc   +1 more source

Risk factors for denosumab-related osteonecrosis of the jaw: a pharmacovigilance study using the U.S. FDA adverse event reporting system database. [PDF]

Front Endocrinol (Lausanne)
Bai H, Wang J, Han X, Li H, Nie X, Wang G.   +5 more
europepmc   +1 more source

Resource utilization in cancer patients with bisphosphonate-associated osteonecrosis of the jaw. [PDF]

Oral Dis, 2014
Najm MS, Solomon DH, Woo SB, Treister NS.   +3 more
europepmc   +1 more source

Low-Level Laser Therapy in the Management of Bisphosphonate-Related Osteonecrosis of the Jaw. [PDF]

J Clin Med
Bitonti V, Franco R, Cigni L, Familiari D, Gravili G, Vazzana G, di Michele P.   +6 more
europepmc   +1 more source